Zynex Investors Reminded of Deadline in Lawsuit

Bernstein Liebhard LLP warns Zynex, Inc. shareholders of impending deadline to join class action lawsuit.

Apr. 9, 2026 at 2:40pm

Got story updates? Submit your updates here. ›

A photorealistic studio still life featuring a stack of legal documents, a gavel, and a calculator on a clean, monochromatic background, conceptually representing the abstract corporate litigation and financial risks facing Zynex and its investors.A high-stakes legal battle over alleged corporate misconduct could have major financial implications for Zynex and its shareholders.NYC Today

Bernstein Liebhard LLP, a prominent law firm, has issued a notice to shareholders of Zynex, Inc. (ZYXIQ) regarding an upcoming deadline to join a class action lawsuit against the company. The lawsuit alleges various securities law violations by Zynex and its leadership.

Why it matters

As a publicly traded medical device company, Zynex faces serious legal and financial risks if found liable in this class action lawsuit. The outcome could significantly impact the company's stock price and future operations, making it an important issue for current and prospective Zynex investors.

The details

The class action lawsuit against Zynex, Inc. alleges the company and its executives made false and misleading statements about the company's business, operations, and prospects. Shareholders who purchased Zynex stock during the class period are eligible to join the lawsuit and potentially recover losses.

  • The class period for the lawsuit is from January 1, 2025 to April 1, 2026.
  • The deadline for shareholders to join the class action lawsuit is April 30, 2026.

The players

Bernstein Liebhard LLP

A prominent law firm that specializes in securities class action lawsuits and has filed the lawsuit against Zynex, Inc.

Zynex, Inc.

A publicly traded medical device company that is the defendant in the class action lawsuit.

Got photos? Submit your photos here. ›

What they’re saying

“We urge Zynex shareholders to contact us before the April 30th deadline to discuss their legal rights in this matter.”

— Laurence Rosen, Managing Partner, Bernstein Liebhard LLP

What’s next

Shareholders have until April 30, 2026 to join the class action lawsuit against Zynex, Inc.

The takeaway

This lawsuit highlights the legal and financial risks that publicly traded medical device companies like Zynex face if they are accused of securities law violations. Investors will be closely watching the outcome, as it could significantly impact Zynex's stock price and future prospects.